Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2025-06-10 00:00:00 ET · period of report 2025-06-09 · accession 0001140361-25-022113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-10 | 2025-06-09 | ADMA | Grossman Jerrold B | Dir | M - OptEx | $5.00 | +10.0K | 488.2K | +2% | +$50.0K |
| D | 2025-06-10 | 2025-06-09 | ADMA | Grossman Jerrold B | Dir | S - Sale+OE | $21.31 | -10.0K | 478.2K | -2% | -$213.1K |
| D | 2025-06-10 | 2025-06-09 | ADMA | Grossman Jerrold B | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-09 | M | A | 10,000 | $5.00 | 488,194 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-09 | S | D | 10,000 | $21.31 | 478,194 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.29 to $21.35. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which will vest in full on February 19, 2026, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 467,305 shares of common stock owned by the reporting person. |
| 3 | Derivative | Stock Option (right to buy) | 2025-06-09 | M | D | 10,000 | $0.00 | 0 | D | $5.00 · — to 2027-02-14 | 10,000 Common Stock | (F7) These options were granted on February 14, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on February 14, 2019. |